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Objective: Natural killer (NK) cells are understudied in the context of metabolic disease and obesity. The goal of
this study was to define the effect of NK cell ablation on systemic inflammation and glucose homeostasis in
murine obesity.
Methods: A transgenic murine model was used to study the effect of NK cell ablation on systemic
inflammation and glucose homeostasis in the context of diet-induced obesity using flow cytometry,
QRTPCR, and glucose tolerance and insulin sensitivity testing.
Results: NK cell ablation achieved a three to fourfold decrease in NK cells but had no effect on T-cell
levels in adipose tissues and spleen. NK cell ablation was associated with decreased total macrophage
infiltration in intra-abdominal adipose tissue, but macrophage infiltration in subcutaneous adipose tissue
and spleen was unaffected. NK cell ablation was associated with modest improvement in insulin sensitiv-
ity but had no effect on tissue transcript levels of inflammatory cytokines.
Conclusions: NK cells play a role in promoting intra-abdominal adipose tissue macrophage infiltration
and systemic insulin resistance in obesity.
Obesity (2014) 22, 2109–2114. doi:10.1002/oby.20823
Introduction
NK cells are increased in murine and human obesity and implicated in
obesity-related inflammation (1-8), suggesting a role in metabolic disease.
These findings prompted the current study, the goal of which was to deter-
mine the effect of in vivo NK cell ablation on systemic inflammation and
glucose homeostasis in murine obesity. We used mice containing a trans-
gene encoding Cre recombinase under control of the NK-cell-specific
NKp46 promoter along with a transgene that permits diphtheria toxin
(DT)-induced ablation of Cre-expressing cells (9). We demonstrate that
NK cell ablation attenuates intra-abdominal adipose tissue macrophage
(ATM) infiltration and induces modest improvement in systemic insulin
sensitivity. This is the first report to describe the effect of NK cell ablation
on metabolic disease in an in vivo obesity model.
Methods
Animals
Research adhered to NIH, Oregon Health & Science University, and
University of Michigan guidelines. C57Bl/6 NKp46-Cre transgenic
mice (from Dr. Eric Vivier and INSERM) and C57Bl/6 mice with a
50 loxP-stop codon-loxP huDTR transgene (Jackson Laboratory, Bar
Harbor, ME) were crossed to generate mice heterozygous for the
NKp46-Cre transgene and homozygous for the flox-stop codon-
huDTR transgene (experimental Cre1 mice) (9). Mice homozygous
for the flox-stop huDTR transgene but lacking the NKp46-Cre trans-
gene were controls (Cre2 mice). Six-week-old littermate male mice
were maintained on high-fat diet (HFD, 60% fat; Research Diets
Inc., New Brunswick, NJ) for 18 weeks. Mice received a 3.5-week
course of biweekly intraperitoneal (IP) injections (7 doses) of 500
ng of DT in 500 mL phosphate buffered saline (PBS) (Sigma-Aldrich
Inc., St. Louis, MO) beginning at week 14 after initiation of HFD
until sacrifice at the end of week 18 of HFD. Glucose tolerance test-
ing (GTT) was performed at week 17, followed by insulin tolerance
testing (ITT) then sacrifice at week 18 on the fourth day after final
DT injection. For GTT and ITT, 12-h fasted mice received either
glucose IP (2 g/kg) or recombinant human insulin IP (0.75 units/kg)
and tail vein blood glucose was measured. Liver, spleen, intra-
abdominal adipose tissue (IAT, epididymal fat pad), and subcutane-
ous adipose tissue (SAT, subcutaneous flank fat pad) were har-
vested, and splenocytes and SVF isolated (8). RNA from liver was
1 Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan, USA. Correspondence: Robert W. O’Rourke (rorourke@umich.edu)
2 Department of Surgery, Ann Arbor Veteran’s Administration Hospital, Ann Arbor, Michigan, USA 3 Department of Medical Genetics, Oregon Health &
Science University, Portland, Oregon, USA 4 Department of Pediatrics, Oregon Health & Science University, Portland, Oregon, USA 5 Graduate Program in
Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA 6 Department Pediatrics and Communicable Diseases, University of
Michigan Health System, Ann Arbor, Michigan, USA 7 Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann
Arbor, Michigan, USA
Funding agencies: Supported by National Institutes of Health Grants DK095050, DK097449 (RWO), DK090262, DK092873 (CNL), DK070333 (DLM).
Disclosure: The authors have no conflicts of interest.
Author contributions: RWO conceived and designed experiments and wrote the manuscript. CNL, DLM contributed to experiment conception and manuscript drafting.
KAM, CKN, PS, GDG, and MS carried out experiments and reviewed the manuscript.
Received: 17 April 2014; Accepted: 11 June 2014; Published online 24 June 2014. doi:10.1002/oby.20823
www.obesityjournal.org Obesity | VOLUME 22 | NUMBER 10 | OCTOBER 2014 2109
Brief Cutting Edge Report
OBESITY BIOLOGY AND INTEGRATED PHYSIOLOGY
Obesity
Figure 1 Effects of NK cell ablation on tissue leukocyte frequencies. (A) Flow cytometry gating strategy:
representative scatterplots from IATSVF demonstrating flow cytometry gating strategy. After exclusion of
doublets and nonviable cells, CD451 cells were gated. Macrophages (F4/801CD11b1) were defined by
sequential gating on F4/801 cells followed by CD11b1 cells. CD11c1 cells, CD2061 cells, and
CD11c2CD2062 (double-negative) cells within the F4/801CD11b1 macrophage population were also
studied (overlapping gates displayed). T cells (CD31) were defined by gating on CD31 cells, followed by
gating on CD41 and CD81 T-cell subpopulations. NKT cells were defined by gating on CD31 cells fol-
lowed by gating on NKp46, NK1.1, and DX5 separately. NK cells were defined by gating on CD32 cells,
followed by gating on DX5, NKp46, and NK1.1 separately (see B). An identical gating strategy was used
for SAT and spleen (not shown).Metric in each scatterplots is percent of parent gate for gated cell popula-
tion. (B) NK cell ablation: representative scatterplots of NK cell markers (NKp46, NK1.1, DX5) in
CD451CD32 cells after exclusion of doublets and nonviable cells in IATSVF and splenocytes (NKp46
only shown). Similar results were observed in SAT (scatterplots not shown). Flow cytometry analysis dem-
onstrates ablation of NK cells in obese DT-treated Cre1 experimental animals but not in obese DT-
treatedCre2 control animals. Metric in each scatterplot is percent of parent gate for gated cell population.
(C) The effect of NK cell ablation on tissue NK cell, T-cell, and NKT cell frequencies: Tissue frequencies of
NK cells, T cells, and NKT cells in obese mice after treatment with DT. Ordinates: percent of designated
cell population within all viable cells isolated from designated tissue. Single asterisk: P< 0.050, double
asterisk:P< 0.100, independent t-test comparing Cre2 and Cre1 cohorts. (D) The effect of NK cell abla-
tion on tissue macrophage frequency: tissue frequencies of macrophages (F4/801CD11b1) in Cre1 and
Cre2 obese mice after treatment with DT. Ordinate: percent of macrophages within all viable cells within
each tissue. Asterisk: P5 0.008, independent t-test comparing Cre2 and Cre1 cohorts. (E) The effect of
NKcell ablation onCD11c/CD206 subpopulation frequencies in IAT: Frequencies of CD11c1, CD2061,
and CD11c2CD2062 macrophage subpopulations in IAT from Cre1 and Cre2 obese mice after treat-
ment with DT. Ordinate: percent of each cell subpopulation within all viable cells. Double asterisk:
P50.071, independent t-test comparingCre2 andCre1 cohorts. n5 15Cre1 and 17Cre2 animals.
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isolated for QRTPCR. Fasting serum insulin levels were measured
with ELISA.
QRTPCR
RNA was reverse-transcribed using random hexamers and QRTPCR
performed using SYBR Green (Applied Biosystems, Inc., Foster
City, CA), transcript-specific primers using actin as an endogenous
control, and 22ddCT quantification method. Primer sequences are
previously published (8).
Flow cytometry
Cells were stained with viable dye and antibodies (CD45-FITC, F4/80-
APC, CD11b-PE-CY7, CD11c-PE, CD206-PerCP-Cy5.5, CD3-PE-Cy7,
CD4-PE, CD8-APC, DX5-APC, NKp46-PerCP-efluor710, and NK1.1-
APC-Cy7; eBiosciences Inc., San Diego, CA) and analyzed on an LSRII
flow cytometer (Becton, Dickinson, Inc., Franklin Lakes, NJ). Data were
analyzed after exclusion of doublets and nonviable cells, using unstained
and isotype controls, restricting analysis to CD451 cells (Figure 1A).
Results
NKp46 transcripts are stable from 6 to 18 weeks
of HFD in wild-type mice IAT
To determine the kinetics of HFD’s effects on IAT NK cell fre-
quency, we compared NKp46 (NK cell) and CD11c (M1 macro-
phage) transcripts in IAT from wild-type C57Bl/6 mice maintained
on HFD for 6 or 18 weeks. NKp46 transcript levels were similar
(fold difference 1.06, P5 0.914) and CD11c transcripts were ele-
vated (fold difference 25.61, P5 0.000) in IAT at 18 weeks com-
pared to 6 weeks of HFD. Subsequent experiments in the transgenic
model studied 18 week HFD.
Systemic NK cell ablation reduces tissue NK cell
frequencies with no effect on T cells in murine
obesity
DT induced a three to fourfold reduction in the frequency of CD3-
NKp461 and CD3-NK1.11 but not CD3-DX51 NK cells in IAT,
SAT, and spleens of Cre1 mice relative to Cre2 mice. NK cell abla-
tion had no effect on the frequency of T cells (CD31), or NKT cells
(CD31DX51, CD31NK1.11) in any tissue, but reduced the fre-
quency of CD31NKp461 NKT cells (Figures 1B and 1C, Table 1).
NK cell ablation reduces IAT macrophages but
has no effect on inflammatory cytokine transcript
levels in murine obesity
NK cell ablation induced a marked reduction in macrophages (F4/
801CD11b1) in IAT but not SAT or spleen in Cre1 mice relative to
Cre2 mice. NK cell ablation had no effect on CD11c1 or CD2061
macrophage frequencies or numbers but was associated with
Figure 1 (Continued)
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decreased frequency and number of CD11c2CD2062 (double-nega-
tive) macrophages in IAT (Figures 1D and 1E, Table 1). Expression
of TNF-a, IL-6, IL-10, CCL2, and IFN-c were similar between Cre1
and Cre2 mice in IAT, SAT, spleen, and liver (data not shown).
NK cell ablation is associated with improved
systemic insulin sensitivity in murine obesity
Cre1 and Cre2 animals gained similar weight on HFD. NK cell
ablation induced modest improvement in insulin sensitivity but had
no effect on glucose tolerance (Figure 2). No difference in fasting
serum insulin levels were observed (0.66 vs. 0.80 ng/mL, Cre1 vs.
Cre2 mice, P5 0.499, independent t-test).
Discussion
Lack of specificity of in vivo ablation methods complicates study of
NK cells (10), a challenge addressed with recent development of a
transgenic model using an NKp46 promoter-driven Cre gene (8,11),
which formed the basis for this manuscript. We observed an increased
macrophage infiltrate in IAT relative to SAT in control Cre2 animals
that did not undergo NK cell ablation, consistent with prior reports in
murine and human obesity. The decrease in macrophages in IAT but
not SAT or spleen with NK cell ablation may be due to the fact that
IAT macrophages are more susceptible to downregulation due to pre-
existing elevated levels, while macrophages in other tissues are at a bio-
logic “floor” not susceptible to further reduction. Qualitative differences
may also exist between macrophages in IAT and other tissues with
respect to NK cell interactions, such as different susceptibilities to NK
cell-derived mediators such as IFN-c, which promotes macrophage
inflammation (6,12,13). Further experiments will be necessary to iden-
tify NK cell-derived factors that regulate macrophages in obesity.
NK cell ablation was associated with a decrease in IAT of
CD11c2CD2062 (double-negative) ATM but did not affect the propor-
tions of CD11c1 ATM, a diabetogenic subpopulation enriched in obesity
(14), or CD2061 ATM, an M2 subpopulation, suggesting that NK cells
do not regulate ATM phenotype with respect to these markers. NK cell
ablation did not affect T cells, which are implicated in obesity-related
inflammation and insulin resistance (15,16). The lack of effect of NK cell
ablation on CD11c, ATM, CD206 ATM, and/or T cells may explain the
only modest improvement in systemic insulin sensitivity and the lack of
effect on inflammatory transcripts. The improvement in insulin sensitivity
but not glucose tolerance suggests that NK cells may selectively regulate
peripheral insulin sensitivity rather than insulin secretion. Studies with
euglycemic clamps will be necessary to resolve this issue. Finally, in the
absence of glucose homeostasis data from mice fed normal chow, and
given the apparent disconnect between inflammation and improved insu-
lin action in ablated mice, we cannot exclude the possibility that NK cells
may attenuate peripheral insulin action in nonobese mice as well.
Despite specificity for NK cells, NKp46 is expressed by other cell
types (17,18). DT induced decreased the frequency of
CD31NKp461 NKT cells, a limitation of this model. In addition,
while DT induced ablation of CD32NKp461 and CD32NK1.11
cells, CD32DX51 cells were preserved. DX5 is expressed on T
cells, NKT cells, fibroblasts, and platelets (8,19). Persistent
CD32DX51 cells likely represent DT-resistant non-NK cells.
Ablation accomplished a three to fourfold decrease in NK cells. Higher
doses and/or longer courses of DT may accomplish more profound abla-
tion with different metabolic effects, and represent avenues for future
research. As tools develop, study of tissue-specific ablation will further
elucidate the role of NK cells in obesity. We observed no difference in
IAT NKp46 transcript levels in wild-type mice fed HFD for 6 weeks
compared to 18 weeks, suggesting that IAT NK cell infiltration does not
change substantially from 6 to 18 weeks of HFD; CD11c transcripts in
contrast were markedly elevated at 18 compared to 6 weeks. We elected
to study 18 week HFD in this manuscript to determine if NK cell
TABLE 1 Cells per gram of adipose tissue based on flow cytometry data, calculated by multiplying frequency of each cell
subpopulation by each parent gate (including CD451 cell gate, as shown in Figure 1) and by total SVF cell yield per gram
of tissue; P-values derived from independent t-test comparing Cre2 and Cre1 animal cohorts
Cells/gram adipose tissue IAT SAT
Cell subset Cell subpopulation Cre2 Cre1 P-value Cre2 Cre1 P-value
NK cells CD32DX51 97,336 44,100 0.162 14,507 9,979 0.239
CD32NKp461 96,246 20,153 0.014 16,093 4,677 0.039
CD32NK1.11 110,589 29,004 0.007 18,238 7,800 0.050
NKT cells CD31DX51 41,636 22,171 0.328 11,503 11,395 0.927
CD31NKp461 24,211 8,014 0.038 13,786 5,600 0.022
CD31NK1.11 28,627 25,074 0.738 10,454 12,290 0.491
T cells CD31 417,651 312,506 0.492 140,653 35,288 0.304
CD31CD41 143,817 142,029 0.977 56,674 12,976 0.303
CD31CD81 171,556 90,104 0.247 70,855 21,217 0.160
ATM F4/801CD11b1 487,951 211,011 0.008 47,028 52,950 0.731
F4/801CD11b1CD11c1 291,038 225,072 0.621 19,809 25,280 0.656
F4/801CD11b1CD2061 278,054 200,535 0.573 51,141 44,935 0.592
F4/801CD11b1CD112CD2062 373,274 197,938 0.078 41,843 27,035 0.496
These data parallel the frequency data presented in Figure 1. Bolded P-values are <0.100.
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ablation regulates metabolism in the face of an established obesity-
induced macrophage infiltrate. Future research will study the kinetics of
the effects of HFD on NK cells over shorter durations of HFD.
Our findings support a role for NK cells in regulating IATATM
infiltration and contributing to systemic insulin resistance in obesity.
Despite these effects, NK cell ablation is not sufficient to com-
pletely resolve inflammation or metabolic dysfunction, suggesting
that targeting NK cells alone will not be sufficient to treat obesity-
related metabolic disease.O
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